# PRAGUE-25 Trial. Catheter Ablation vs. AADs and Risk Factor Modification.

Study · id `cardio:ct-nct04011800` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04011800](<https://clinicaltrials.gov/study/NCT04011800>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04011800

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 212 participants.

## Technical summary

Registry record NCT04011800. Randomized; no masking; primary purpose treatment. Start 2021-05-01 (actual); primary completion 2025-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 212 participants (planned count; ClinicalTrials.gov record NCT04011800, source copy `cardio:ctgov-nct04011800-2023-11-14`, retrieved 2026-10-26)
- Started: 2021-05-01 (actual) (ClinicalTrials.gov record NCT04011800, source copy `cardio:ctgov-nct04011800-2023-11-14`, retrieved 2026-10-26)
- Primary completion: 2025-06-30 (anticipated) (ClinicalTrials.gov record NCT04011800, source copy `cardio:ctgov-nct04011800-2023-11-14`, retrieved 2026-10-26)
- Completion: 2025-12-30 (anticipated) (ClinicalTrials.gov record NCT04011800, source copy `cardio:ctgov-nct04011800-2023-11-14`, retrieved 2026-10-26)
- Countries: Czechia (ClinicalTrials.gov record NCT04011800, source copy `cardio:ctgov-nct04011800-2023-11-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04011800-2023-11-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: PRAGUE-25 Trial. Catheter Ablation vs. AADs and Risk Factor Modification.
- Condition: Atrial Fibrillation
- Intervention (Procedure): Catheter ablation
- Intervention (Combination product): Risk Factor Modification
- Lead sponsor: Charles University, Czech Republic
- Lead sponsor class: OTHER
- Collaborator: General Teaching Hospital, Prague
- Collaborator class: OTHER
- Collaborator: Brno University Hospital
- Collaborator class: OTHER
- Collaborator: Hospital Podlesi
- Collaborator class: OTHER
- Collaborator: Regional Hospital Liberec
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Charles University, Czech Republic (`cardio:org-charles-university-czech-republic`)
- Registry lists this organization as a collaborator: Brno University Hospital (`cardio:org-brno-university-hospital`)

## Provenance

Content hash: 66e3817f4c66b9ae938cca5c5b4ab7ab2558cfec1161d20c158f30e81b44c011
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
